Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment

Kazem Mashayekhi,Khashayarsha Khazaie,William A. Faubion,Gloria B. Kim
DOI: https://doi.org/10.1016/j.bioactmat.2024.03.030
IF: 18.9
2024-04-25
Bioactive Materials
Abstract:Highlights • Biomaterial-enhanced Treg therapy has the potential to transform organ transplantation and autoimmune disease treatments by enhancing Treg efficacy. • Interventions utilizing biomaterials can improve Treg migration, stability, and suppressive abilities in target tissues, maximizing therapeutic impact. • The safety and efficacy demonstrated by biomaterial-based Treg therapy lay the groundwork for future treatments in this field. • Biomaterial properties are crucial in guiding the design of platforms that support Treg function, thereby enhancing treatment precision. • Biomaterials provide diverse options for modulating immune responses, expanding the potential applications of Treg therapy. Regulatory T cells (Tregs) are crucial for preserving tolerance in the body, rendering Treg immunotherapy a promising treatment option for both organ transplants and autoimmune diseases. Presently, organ transplant recipients must undergo lifelong immunosuppression to prevent allograft rejection, while autoimmune disorders lack definitive cures. In the last years, there has been notable advancement in comprehending the biology of both antigen-specific and polyclonal Tregs. Clinical trials involving Tregs have demonstrated their safety and effectiveness. To maximize the efficacy of Treg immunotherapy, it is essential for these cells to migrate to specific target tissues, maintain stability within local organs, bolster their suppressive capabilities, and ensure their intended function's longevity. In pursuit of these goals, the utilization of biomaterials emerges as an attractive supportive strategy for Treg immunotherapy in addressing these challenges. As a result, the prospect of employing biomaterial-enhanced Treg immunotherapy holds tremendous promise as a treatment option for organ transplant recipients and individuals grappling with autoimmune diseases in the near future. This paper introduces strategies based on biomaterial-assisted Treg immunotherapy to enhance transplant medicine and autoimmune treatments. Graphical abstract Download : Download high-res image (316KB) Download : Download full-size image
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?